Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Trichomegaly of the eyelashes following treatment with cetuximab.

× No keyword cloud information.

14 in total

Review 1. Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.

Authors: Z Reguiai; J B Bachet; C Bachmeyer; L Peuvrel; M Beylot-Barry; M Bezier; E Boucher; C Chevelle; P Colin; R Guimbaud; L Mineur; M A Richard; P Artru; P Dufour; J M Gornet; E Samalin; R J Bensadoun; M Ychou; T André; B Dreno; O Bouché
Journal: Support Care Cancer Date: 2012-04-27 Impact factor: 3.603

2. Eyelash trichomegaly secondary to panitumumab therapy.

Authors: L G T Morris; H S Hochster; M D Delacure
Journal: Curr Oncol Date: 2011-06 Impact factor: 3.677

3. Eyelash trichomegaly following treatment with erlotinib in a non-small cell lung cancer patient: A case report and literature review.

Authors: Shan-Bing Wang; Kai-Jian Lei; Jia-Pei Liu; Yu-Ming Jia
Journal: Oncol Lett Date: 2015-05-26 Impact factor: 2.967

Review 4. Hair disorders in patients with cancer.

Authors: Azael Freites-Martinez; Jerry Shapiro; Shari Goldfarb; Julie Nangia; Joaquin J Jimenez; Ralf Paus; Mario E Lacouture
Journal: J Am Acad Dermatol Date: 2018-04-14 Impact factor: 11.527

5. Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Authors: M Fakih; M Vincent
Journal: Curr Oncol Date: 2010-07 Impact factor: 3.677

6. Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.

Authors: Per Pfeiffer; Camilla Qvortrup; Jon K Bjerregaard
Journal: Onco Targets Ther Date: 2009-02-18 Impact factor: 4.147

7. Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year review.

Authors: Durga S Borkar; Mario E Lacouture; Surendra Basti
Journal: Support Care Cancer Date: 2012-11-15 Impact factor: 3.603

Trichomegaly of the eyelashes following treatment with cetuximab.